In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

作者：zishanshi随着通用大模型向着agentic以及GUI理解增强的方向发展，现在Gemini 3 Flash等通用大模型已经可以直接用来搭建一个效果还不错的GUI ...